Resistance to a triple combination of broad-spectrum anthelmintics in naturally-acquired Ostertagia circumcincta infections in sheep

N Z Vet J. 2006 Feb;54(1):47-9. doi: 10.1080/00480169.2006.36604.

Abstract

Aim: To measure the efficacy of two macrocyclic lactone-levamisole-benzimidazole combination drenches against naturally-acquired abomasal nematode infections on a sheep farm in the North Island, New Zealand.

Methods: Eighteen lambs carrying naturally-acquired worm burdens were removed from pasture and randomly allocated to one of three equal-sized groups, consisting of an untreated control group and two treatment groups. One treatment group was given a single oral dose of a triple-combination anthelmintic administered at the manufacturer's recommended dose rate of 0.2 mg/kg ivermectin, 7.5 mg/kg levamisole and 5.0 mg/kg albendazole. The other treatment group received a similar dose of another triple-combination drench consisting of 0.2 mg/kg abamectin, 8.0 mg/kg levamisole and 4.5 mg/kg oxfendazole. Worm counts were carried out post mortem on the abomasa of all animals in all groups, 10 days after treatment.

Results: While the abamectin-levamisole-oxfendazole combination was highly effective against all three abomasal nematode species present, the ivermectin-levamisole-albendazole combination was not. In the latter instance, a reduction of only 78% was achieved against infections of Ostertagia (=Teladorsagia) circumcincta.

Conclusions: These results provide evidence of resistance to an ivermectin-levamisole-albendazole combination drench by O. circumcincta.

Clinical relevance: Besides representing the first confirmed report of resistance to a combination drench consisting of three broad-spectrum anthelmintics, the present results provide further evidence of the continuing escalation of multiple anthelmintic resistance in sheep nematodes in New Zealand.

MeSH terms

  • Albendazole / pharmacology
  • Albendazole / therapeutic use
  • Animals
  • Anthelmintics / pharmacology
  • Anthelmintics / therapeutic use*
  • Benzimidazoles / pharmacology
  • Benzimidazoles / therapeutic use
  • Drug Resistance
  • Drug Therapy, Combination
  • Ivermectin / analogs & derivatives
  • Ivermectin / pharmacology
  • Ivermectin / therapeutic use
  • Levamisole / pharmacology
  • Levamisole / therapeutic use
  • Male
  • New Zealand
  • Ostertagiasis / drug therapy
  • Ostertagiasis / veterinary*
  • Parasitic Sensitivity Tests / veterinary
  • Random Allocation
  • Sheep
  • Sheep Diseases / drug therapy*
  • Treatment Outcome

Substances

  • Anthelmintics
  • Benzimidazoles
  • Levamisole
  • abamectin
  • Ivermectin
  • Albendazole
  • oxfendazole